{"nct_id":"NCT01072149","title":"A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo","status":"COMPLETED","status_verified_date":"2017-10","start_date":"2010-01-01","start_date_type":null,"primary_completion_date":"2010-07-01","primary_completion_date_type":"ACTUAL","completion_date":"2010-07-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}